Literature DB >> 26077894

Correlation between peri-implant sulcular fluid rate and expression of collagenase2 (MMP8).

Emilia Janska1,2, Barbara Mohr3, Gerhard Wahl2.   

Abstract

OBJECTIVES: The rapidly increasing numbers of inserted dental implants and the growing incidence of peri-implant mucositis and peri-implantitis with the current absence of reliable disease risk prediction highlight the importance of early and sensitive diagnosis of possible disease progression. The aim of this study is to assess quantitative and qualitative analysis of peri-implant sulcular fluid (PISF) during implant maintenance control and to identify whether there is a positive correlation and statistical significance between peri-implant sulcular fluid volume results and collagenase2 level obtained from both superficial and fundus area of peri-implant sulcus. MATERIAL AND
METHOD: Twenty-seven implants from patients under recall provided peri-implant sulcular fluid volume samples, which were collected with the Periotron 8000 micro-moisture meter, and collagenase2 levels, which were assessed using dentoTest aMMP8. Statistical analysis was obtained using Spearman's correlation.
RESULTS: Positive correlation was found between collagenase2 collected from sulcular and fundus areas on both mesial and distal sides. There was correlation between peri-implant sulcular fluid volume and collagenase2 level from fundus and distal area, but not from the mesial and superficial area.
CONCLUSIONS: Examination of collagenase2 is a sensitive method when examining early inflammatory changes but depends from the depth of the sample collection in the gingival pocket. CLINICAL RELEVANCE: The examination of MMP8 seems to be a more sensitive method than the analysis of peri-implant sulcular fluid to detect peri-implant mucositis and peri-implantitis.

Entities:  

Keywords:  Collagenase2; Matrix-metallo-proteinase 8; Peri-implant mucositis; Peri-implant sulcular fluid; Peri-implantitis

Mesh:

Substances:

Year:  2015        PMID: 26077894     DOI: 10.1007/s00784-015-1501-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  26 in total

Review 1.  The diagnosis and treatment of peri-implantitis.

Authors:  A Mombelli; N P Lang
Journal:  Periodontol 2000       Date:  1998-06       Impact factor: 7.589

Review 2.  A review on peri-implant crevicular fluid assays potential in monitoring and predicting peri-implant tissue responses.

Authors:  E G Kaklamanos; L Tsalikis
Journal:  J Int Acad Periodontol       Date:  2002-04

Review 3.  Analysis of gingival crevice fluid and risk of progression of periodontitis.

Authors:  Gary C Armitage
Journal:  Periodontol 2000       Date:  2004       Impact factor: 7.589

4.  Evaluation of periimplant crevicular fluid prostaglandin E2 and matrix metalloproteinase-8 levels from health to periimplant disease status: a prospective study.

Authors:  Cansu Basegmez; Serdar Yalcin; Funda Yalcin; Selim Ersanli; Eitan Mijiritsky
Journal:  Implant Dent       Date:  2012-08       Impact factor: 2.454

5.  [Comparative study of the reproducibility of the measurements of the Periotron].

Authors:  H Schorn; W Geurtsen; W Ketterl
Journal:  ZWR       Date:  1986-08

Review 6.  Crevicular fluid analysis around two failing dental implants: a clinical report.

Authors:  D A Curtis; R Kao; O Plesh; F Finzen; L Franz
Journal:  J Prosthodont       Date:  1997-09       Impact factor: 2.752

Review 7.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

8.  Neutrophil elastase and its inhibitors in human gingival crevicular fluid during experimental gingivitis.

Authors:  C Giannopoulou; E Andersen; C Demeurisse; G Cimasoni
Journal:  J Dent Res       Date:  1992-02       Impact factor: 6.116

9.  Matrix metalloproteinase-8 is the major potential collagenase in active peri-implantitis.

Authors:  Hikaru Arakawa; Junji Uehara; Emilio Satoshi Hara; Wataru Sonoyama; Aya Kimura; Manabu Kanyama; Yoshizo Matsuka; Takuo Kuboki
Journal:  J Prosthodont Res       Date:  2012-10-18       Impact factor: 4.642

10.  Local and systemic responses in matrix metalloproteinase 8-deficient mice during Porphyromonas gingivalis-induced periodontitis.

Authors:  Heidi Kuula; Tuula Salo; Emma Pirilä; Anita M Tuomainen; Matti Jauhiainen; Veli-Jukka Uitto; Leo Tjäderhane; Pirkko J Pussinen; Timo Sorsa
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

View more
  4 in total

1.  Evaluation of Metalloproteinase-8 Levels in Crevicular Fluid of Patients with Healthy Implants or Periodontitis.

Authors:  Paweł Aleksandrowicz; Paulina Żelechowska; Justyna Agier; Katarzyna Starska; Krzysztof Kędzierski; Joanna Wysokińska-Miszczuk; Ewa Brzezińska-Błaszczyk
Journal:  Mediators Inflamm       Date:  2017-07-05       Impact factor: 4.711

2.  Levels of Gene Expression of Immunological Biomarkers in Peri-Implant and Periodontal Tissues.

Authors:  Luciene Cristina Figueiredo; Bruno Bueno-Silva; Cristiana Fernandes Plutarco Nogueira; Leonardo Carneiro Valadares; Katia Marina Morilla Garcia; Givelton Coimbra da Luz Filho; Luciano Milanello; Felipe Machado Esteves; Jamil Awad Shibli; Tamires Szeremeske Miranda
Journal:  Int J Environ Res Public Health       Date:  2020-12-06       Impact factor: 3.390

Review 3.  Matrix Metalloproteinase-8 as an Inflammatory and Prevention Biomarker in Periodontal and Peri-Implant Diseases.

Authors:  Ahmed Al-Majid; Saeed Alassiri; Nilminie Rathnayake; Taina Tervahartiala; Dirk-Rolf Gieselmann; Timo Sorsa
Journal:  Int J Dent       Date:  2018-09-16

4.  Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis.

Authors:  Darius Gleiznys; Albertas Kriauciunas; Julius Maminskas; Arturas Stumbras; Dalia Giedrimiene; Christine Niekrash; Alvydas Gleiznys; Jurgina Sakalauskiene; Astra Vitkauskiene
Journal:  Med Sci Monit       Date:  2021-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.